| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Comparison of Items and Constructs of Standardized Health-Related Quality of Life and Mental Well-Being Measures
|
Mao, Zhuxin
|
|
|
27 |
4 |
p. 478-489
|
artikel
|
| 2 |
A Review of Meaningful Change Thresholds for EORTC QLQ-C30 and FACT-G Within Oncology
|
Clarke, Nathan A.
|
|
|
27 |
4 |
p. 458-468
|
artikel
|
| 3 |
Benefit-Harm Analysis for Informed Decision Making on Participating in Colorectal Cancer Screening: A Modeling Study
|
Yebyo, Henock G.
|
|
|
27 |
4 |
p. 397-404
|
artikel
|
| 4 |
Cost and Utility Estimates per Modified Rankin Scale Score up to 2 Years Post Stroke: Data to Inform Economic Evaluations From a Societal Perspective
|
Pinckaers, Florentina M.E.
|
|
|
27 |
4 |
p. 441-448
|
artikel
|
| 5 |
Cost of Illness of Head and Neck Cancer in Sweden
|
Silfverschiöld, Maria
|
|
|
27 |
4 |
p. 425-432
|
artikel
|
| 6 |
Discrete Event Simulation to Incorporate Infusion Wait-Time When Assessing Cost-Effectiveness of a Chimeric-Antigen Receptor T Cell Therapy
|
Gye, Amy
|
|
|
27 |
4 |
p. 415-424
|
artikel
|
| 7 |
Economic Evaluation of an Enhanced Post-Discharge Home-Based Care Program for Stroke Survivors
|
Wong, Arkers Kwan Ching
|
|
|
27 |
4 |
p. 405-414
|
artikel
|
| 8 |
Editorial Board
|
|
|
|
27 |
4 |
p. v
|
artikel
|
| 9 |
Estimating a Minimal Important Difference for the EQ-5D-5L Utility Index in Dialysis Patients
|
Siriwardana, Amanda N.
|
|
|
27 |
4 |
p. 469-477
|
artikel
|
| 10 |
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework
|
Jiao, Boshen
|
|
|
27 |
4 |
p. 433-440
|
artikel
|
| 11 |
Evaluating Recall Periods for Patient-Reported Outcome Measures: A Systematic Review of Quantitative Methods
|
Arizmendi, Cara
|
|
|
27 |
4 |
p. 518-526
|
artikel
|
| 12 |
Exploring the Comparability Between EQ-5D and the EQ Health and Wellbeing in the General Australian Population
|
Lee, Peter
|
|
|
27 |
4 |
p. 508-517
|
artikel
|
| 13 |
Partial Orphan Cancer Drugs: US Food and Drug Administration Approval, Clinical Benefit, Trials, Epidemiology, Price, Beneficiaries, and Spending
|
Michaeli, Thomas
|
|
|
27 |
4 |
p. 449-457
|
artikel
|
| 14 |
Table of Contents
|
|
|
|
27 |
4 |
p. i-iv
|
artikel
|
| 15 |
The Cost of Atrial Fibrillation: A Systematic Review
|
Buja, Alessandra
|
|
|
27 |
4 |
p. 527-541
|
artikel
|
| 16 |
The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation
|
Szafranski, Kirk
|
|
|
27 |
4 |
p. 500-507
|
artikel
|
| 17 |
The PICOTS-ComTeC Framework for Defining Digital Health Interventions: An ISPOR Special Interest Group Report
|
Zrubka, Zsombor
|
|
|
27 |
4 |
p. 383-396
|
artikel
|
| 18 |
Validation of China Health-Related Outcomes Measures-Cardiovascular Disease
|
Li, Xue
|
|
|
27 |
4 |
p. 490-499
|
artikel
|
Tijdschrift beschrijving